======= RPS6KA3 ======= == Gene Information == * **Official Symbol**: RPS6KA3 * **Official Name**: ribosomal protein S6 kinase A3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6197|6197]] * **UniProt**: [[https://www.uniprot.org/uniprot/P51812|P51812]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RPS6KA3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RPS6KA3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/300075|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 non-identical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Mutations in this gene have been associated with Coffin-Lowry syndrome (CLS). [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1. In fibroblast, is required for EGF-stimulated phosphorylation of CREB1 and histone H3 at 'Ser-10', which results in the subsequent transcriptional activation of several immediate-early genes. In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP. Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity. Phosphorylates RPS6 in response to serum or EGF via an mTOR- independent mechanism and promotes translation initiation by facilitating assembly of the preinitiation complex. In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation. Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway. Mediates cell survival by phosphorylating the pro- apoptotic proteins BAD and DAPK1 and suppressing their pro- apoptotic function. Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression. In LPS-stimulated dendritic cells, is involved in TLR4-induced macropinocytosis, and in myeloma cells, acts as effector of FGFR3-mediated transformation signaling, after direct phosphorylation at Tyr-529 by FGFR3. Negatively regulates EGF-induced MAPK1/3 phosphorylation via phosphorylation of SOS1. Phosphorylates SOS1 at 'Ser-1134' and 'Ser-1161' that create YWHAB and YWHAE binding sites and which contribute to the negative regulation of MAPK1/3 phosphorylation (By similarity). Phosphorylates EPHA2 at 'Ser-897', the RPS6KA- EPHA2 signaling pathway controls cell migration (PubMed:26158630). {ECO:0000250|UniProtKB:P18654, ECO:0000269|PubMed:10436156, ECO:0000269|PubMed:16213824, ECO:0000269|PubMed:16223362, ECO:0000269|PubMed:17360704, ECO:0000269|PubMed:18722121, ECO:0000269|PubMed:26158630, ECO:0000269|PubMed:8250835, ECO:0000269|PubMed:9770464}. |Pkinase| |Pkinase Tyr| |Pkinase C| |ribosomal protein S6 kinase activity| |regulation of translation in response to stress| |cysteine-type endopeptidase inhibitor activity involved in apoptotic process| |negative regulation of cysteine-type endopeptidase activity involved in apoptotic process| |negative regulation of cysteine-type endopeptidase activity| |toll-like receptor signaling pathway| |regulation of DNA-templated transcription in response to stress| |pattern recognition receptor signaling pathway| |positive regulation of cell growth| |peptidyl-serine phosphorylation| |peptidyl-serine modification| |regulation of cysteine-type endopeptidase activity involved in apoptotic process| |magnesium ion binding| |innate immune response-activating signal transduction| |protein kinase activity| |regulation of cysteine-type endopeptidase activity| |negative regulation of endopeptidase activity| |negative regulation of peptidase activity| |activation of innate immune response| |positive regulation of growth| |response to lipopolysaccharide| |response to molecule of bacterial origin| |positive regulation of innate immune response| |negative regulation of proteolysis| |regulation of translation| |positive regulation of response to biotic stimulus| |protein serine/threonine kinase activity| |regulation of cellular amide metabolic process| |regulation of endopeptidase activity| |regulation of cell growth| |regulation of peptidase activity| |regulation of innate immune response| |negative regulation of hydrolase activity| |protein kinase binding| |positive regulation of defense response| |skeletal system development| |positive regulation of multi-organism process| |regulation of response to biotic stimulus| |posttranscriptional regulation of gene expression| |immune response-activating signal transduction| |immune response-regulating signaling pathway| |positive regulation of response to external stimulus| |activation of immune response| |regulation of growth| |response to bacterium| |regulation of proteolysis| |regulation of defense response| |regulation of multi-organism process| |negative regulation of catalytic activity| |response to lipid| |positive regulation of immune response| |peptidyl-amino acid modification| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |apoptotic process| |positive regulation of cell differentiation| |protein phosphorylation| |central nervous system development| |negative regulation of cell death| |negative regulation of cellular protein metabolic process| |programmed cell death| |cell death| |regulation of response to external stimulus| |negative regulation of protein metabolic process| |negative regulation of molecular function| |regulation of immune response| |positive regulation of immune system process| |positive regulation of transcription by RNA polymerase II| |regulation of hydrolase activity| |phosphorylation| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |cell cycle| |positive regulation of developmental process| |regulation of response to stress| |ATP binding| |regulation of apoptotic process| |positive regulation of transcription, DNA-templated| |response to oxygen-containing compound| |regulation of programmed cell death| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |regulation of immune system process| |regulation of cell death| |intracellular signal transduction| |cellular response to stress| |positive regulation of RNA metabolic process| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/694 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/26| |bone|0/26| |breast|0/30| |central nervous system|0/49| |cervix|0/4| |colorectal|0/17| |esophagus|0/11| |fibroblast|0/1| |gastric|0/14| |kidney|0/18| |liver|0/19| |lung|0/72| |lymphocyte|0/16| |ovary|0/25| |pancreas|0/22| |peripheral nervous system|0/15| |plasma cell|0/12| |prostate|0/1| |skin|0/20| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/28| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17280 * **Expression level (log2 read counts)**: 6.26 {{:chemogenomics:nalm6 dist.png?nolink |}}